🔗 Share this article

As America proceeds with sweeping revisions to its immunization recommendations, an unexpected name has surfaced somewhat surprisingly: Tracy Beth Høeg, a US-based sports physician and epidemiologist who initially gained attention by questioning COVID-19 shots throughout the global health crisis and has zeroed in on potential deaths following COVID-19 vaccination in her recent time at the Food and Drug Administration.

Proposed Overhauls to Pediatric Vaccine Schedule

Public health authorities had intended to announce radical revisions to the childhood vaccine schedule recently, synchronizing the US with the Danish vaccine program, according to reports – a major change that would place the US at odds with a large portion of the world with insufficient data for public health gain. This reveal has been delayed until the coming year.

Rather than Vinay Prasad, Høeg is scheduled to present at the event. She was newly appointed temporary leader of the FDA’s CDER, the fifth appointee to run the division this calendar year.

A Shift at the FDA

Høeg's temporary position may indicate a closer partnership between the pharmaceutical and biologics branches as Høeg and Dr. Prasad strengthen their influence at the FDA – and it points to a renewed priority upon dismantling already-approved vaccines at the FDA.

Høeg has frequently advocated for ending certain pediatric immunization guidelines in the US so as to align more in line with Denmark, a society with comprehensive healthcare and a number of inhabitants about the population of Wisconsin’s.

To date comments, she has continued to focus on immunizations – usually the domain of Dr. Prasad, chief of the FDA’s Center for Biologics Evaluation and Research (CBER) – instead of pharmaceutical oversight.

Concerns Over Qualifications

Høeg has no apparent background in drug development, oversight or leadership, which has been standard for previous leaders of the Center for Biologics Evaluation and Research. She has served at the FDA as a senior adviser to the agency head and the vaccine center since spring.

“She appears not to have the requisite experience” for overseeing the drug-regulation department, remarked a neurologist and psychiatrist. “She’s never run a scientific study. She has no expertise in managing a large organization. She lacks background in drug approvals.”

Past commissioners of the center would “grasp legal statutes and the research of pharmaceutical innovation”, noted Janet Woodcock. “Clearly, she has not acquired the kind of background that former directors who headed the center have had.”

The drug center has an immense range of responsibilities at the agency, she pointed out.

“Everybody just pays attention on the novel medication approvals, but the generic drug division approves a multitude of generic drugs. There’s a biologic copycat branch, over-the-counter program and more, and all of those must be managed,” she explained. “The responsibility you overlook, that is precisely what that I always told people is going to come back to haunt you.”

Furthermore, a significant administrative aspect to the role, which oversees more than 5,000 employees. “It is a massive administrative position, if you perform it correctly,” she added.

Agency Reaction and Contentious Policies

Regarding inquiries about Høeg’s credentials and whether this selection indicates greater collaboration among agency officials on vaccines, a spokesperson said that the “concerns rely on inaccurate presumptions”.

“Her experience is consistent with the duties of her job,” the official explained, citing the time Høeg spent advising the FDA commissioner on “medication safety and regulatory science, including predictive safety algorithms and immunization monitoring”.

As acting director, Høeg inherits the agency head's recently launched fast-track approval initiative, a disputed one-day therapy clearance system that allegedly concerned her former heads. “How are these medications being selected for this voucher program? Who takes the decisions?” Howard asked. “There’s a lot of secrecy happening at the FDA right now.”

In general, he stated, “the FDA appears to be shifting towards less stringent oversight of most medications, with the exception of shots.”

Established Track Record on Immunizations

Regarding immunizations, Dr. Høeg has a more documented, if problematic, history, Howard have noted. She published a analysis using non-validated crowd-sourced reports to estimate the incidence of heart inflammation following Covid vaccination. She consulted for the state of Florida top health official Dr. Joseph Ladapo, who allegedly have modified findings to indicate COVID-19 vaccines are more dangerous than they are.

Among her “desired changes” for the current federal leadership included revising regulations for novel immunizations and ending “non-essential” vaccines, she stated after the election on a online show. At the agency, Høeg has allegedly suggested preventing adolescent males from obtaining Covid vaccinations.

“She’s an thorough ideologue who begins with her beliefs and reverse-engineers to retrofit the science in a extremely disingenuous, dishonest way,” Howard stated.

Consolidating Power and a “Campaign of Retribution”

Dr. Høeg joined fellow contrarians, {like|